Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply
- PMID: 31553846
- DOI: 10.1056/NEJMc1909693
Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply
Comment on
-
Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer.N Engl J Med. 2019 Sep 26;381(13):1289-1291. doi: 10.1056/NEJMc1909693. N Engl J Med. 2019. PMID: 31553844 No abstract available.
-
Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer.N Engl J Med. 2019 Sep 26;381(13):1289-1290. doi: 10.1056/NEJMc1909693. N Engl J Med. 2019. PMID: 31553845 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical